The evidence base on COVID-19 seeks to provide clinicians, program managers, and community members with credible up-to-date information on the relationship between viral hepatitis and liver disease with COVID-19.
Synthesis on COVID-19 and liver disease
Researchers and experts from across the world have been working rapidly to understand theinteraction of co-morbidities and COVID-19, including liver disease. In this synthesis published in April, Dr. Ward summarized the current status of the evidence on COVID-19 and liver disease.
Clinical Liver Disease series
The Coalition worked with Clinical Liver Disease, a journal of AASLD, to publish an 8 article series related to COVID-19 and liver disease.
Dr. Ward, Director of the Coalition, co-authored two of these articles:
- One article is titled, "The COVID-19 Pandemic: An Epidemiologic, Public Health and Clinical Brief," and was authored with Emory Professor Carlos del Rio.
- The second article is titled, "Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic and was authored with Dr. George Lau, a hepatologist in Hong Kong.
Read the full series here.
Relevant links EASL: https://easl.eu/covid-19-and-the-liver/